medical-devices is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Pulmonary hypertension, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Healthcare story that mention Brandon Fornwalt, all published on August 25, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Brandon Fornwalt
medical-devices is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Pulmonary hypertension, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Healthcare story that mention Brandon Fornwalt, all published on August 25, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 1 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Brandon Fornwalt. Shared-story counts are live from our verified record — not editorial picks.
Tempus AI announced FDA 510(k) clearance for Tempus ECG-PH, an AI-enabled tool that analyzes standard 12-lead ECGs for pulmonary hypertension signs. The device targets symptomatic adults 40 and older, aiming to address underdiagnosis without invasive procedures.
Brandon Fornwalt is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.